[CD5 positive B cell leukemic lymphoma associated with BCL6 rearrangement]

H Hirai1, K Shimura, R Takahashi

  • 1Second Department of Medicine, Kyoto Prefectural University of Medicine.

Insights

This study details a rare case of CD5 positive B-cell lymphoma with BCL6 gene rearrangement presenting without lymphadenopathy. The patient

Area of Science:

  • Hematology
  • Oncology
  • Genetics

Background:

  • CD5 positive B-cell lymphomas are a diverse group of lymphoid malignancies.
  • Rearrangement of the BCL6 gene is observed in various B-cell lymphomas, influencing prognosis and treatment.

Observation:

  • A 59-year-old male presented with fatigue and 70% abnormal lymphocytes in peripheral blood, with a dry bone marrow tap.
  • Tumor cells were positive for CD5, CD19, CD20, HLA-DR, kappa, and sIgM, but negative for CD10.
  • Cytogenetic analysis revealed a complex karyotype with t(3;22) and BCL6 gene rearrangement.

Findings:

  • The patient was diagnosed with CD5 positive B-cell lymphoma.
  • This case is unique due to the rare association of BCL6 rearrangement with a leukemic presentation lacking lymphadenopathy.

Implications:

  • This case highlights the importance of comprehensive diagnostic workup, including cytogenetics, in atypical B-cell lymphoma presentations.
  • Understanding BCL6 rearrangement in leukemic B-cell lymphomas may offer insights into disease pathogenesis and potential therapeutic targets.